For the Inventor, By the Inventor

Enter assignee name

Ness Ziona, Israel

Sol-Gel Technologies Ltd.

USPTO Granted Patents = 41

% Expired Patents = 12.2

CIPO Patents = 4

EPO Patents = 12

Trademarks = 2

Forward Citations = 599

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Ofer Toledano (25 out of 28 patents)

Hanan Sertchook (11 out of 13 patents)

Ori Nov (10 out of 10 patents)

4. Haim Bar-Simantov (10 out of 11 patents)

5. Noa Lapidot (9 out of 29 patents)

6. Claudio Rottman (9 out of 19 patents)

7. Shlomo Magdassi (7 out of 46 patents)

8. David Avnir (7 out of 21 patents)

9. Orit Gans (7 out of 7 patents)

10. Alon Seri-Levy (7 out of 14 patents)

11. Raed Abu-Reziq (5 out of 9 patents)

12. Dorit Marco (5 out of 7 patents)

13. Ofra Levy-Hacham (5 out of 5 patents)

14. Vered Ram (5 out of 5 patents)

15. Karine Neimann (5 out of 7 patents)

Core Competencies:

Therapeutic Treatment

Rosacea

Microcapsules

Metal Oxide Coating

Silica Microspheres

Acne Treatment

Topical Formulations

Sunscreen Composition

Core-Shell Particles

Active Ingredient Encapsulation

Formulation Stability

Sustained Release

41 patents: Sort by Forward Citations

1. RE50804 - Pharmaceutical compositions comprising silica microspheres (2026-02-24),

2. 12295935 - Method for therapeutic treatment of rosacea (2025-05-13),

3. 12257348 - Stabilized microcapsules, method of their preparation and uses thereof (2025-03-25),

4. 12156946 - Method for preparing particles comprising metal oxide coating and particles with metal oxide coating (2024-12-03),

5. 12133919 - Stabilized microcapsules, method of their preparation and uses thereof (2024-11-05),

6. 12070629 - Core stabilized microcapsules, method of their preparation and uses thereof (2024-08-27),

7. 12053546 - Stabilized topical formulations containing core-shell microcapsules (2024-08-06),

8. 11986456 - Method for treatment of rosacea (2024-05-21),

9. 11877997 - Method for providing early onset of action in the treatment of rosacea (2024-01-23),

10. 11865208 - Pharmaceutical compositions comprising silica microspheres (2024-01-09),

11. 11865100 - Method for treatment of rosacea in patients aged 65 years and older (2024-01-09),

12. 11633399 - Treatment of skin disorders with compositions comprising an EGFR inhibitor (2023-04-25),

13. 11628155 - Method for therapeutic treatment of rosacea (2023-04-18),

14. 11541026 - Method for treatment of rosacea (2023-01-03),

15. 11426378 - Method for long-term treatment of rosacea (2022-08-30),

Sol-Gel Technologies Ltd. is a specialty pharmaceutical company that focuses on the development and commercialization of dermatology products. The company utilizes its proprietary technology to create novel and differentiated topical gel formulations. Sol-Gel's products address various skin conditions, including acne, rosacea, and psoriasis. Their innovative products offer improved efficacy and patient convenience compared to traditional creams and ointments, providing better treatment options for patients and healthcare professionals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Sol-Gel Technologies Ltd.

41 Patents

#2 in Ness Ziona

#130 in Israel

#16,646 in the World

Ness Ziona, Israel

Sol-Gel Technologies Ltd.

Forward Citations = 599

43 inventors:

Ofer Toledano (25 out of 28 patents)

Hanan Sertchook (11 out of 13 patents)

Ori Nov (10 out of 10 patents)

4. Haim Bar-Simantov (10 out of 11 patents)

5. Noa Lapidot (9 out of 29 patents)

Please report any incorrect information to [email protected]

Loading…